Pulmonary hypertension in systemic lupus erythematosus

Best Practice and Research: Clinical Rheumatology

Volumn 27, Issue 3, 2013, Pages 425-434

  Schreiber, Benjamin E ^a   Connolly, Michelle J ^a   Coghlan, J Gerry ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Pulmonary arterial hypertension; Pulmonary hypertension; Systemic lupus erythematosus

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; ENDOTHELIN RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; IMATINIB; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; METHOTREXATE; METHYLPREDNISOLONE ACETATE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; RHEUMATOID FACTOR; RO ANTIBODY; SILDENAFIL; TADALAFIL;

ARTERY DILATATION; ARTHRALGIA; ARTHRITIS; ARTICLE; CAPILLAROSCOPY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG MECHANISM; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; FATIGUE; FUNCTIONAL STATUS; HAIR LOSS; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; LYMPHOCYTOPENIA; MOUTH ULCER; OUTCOME ASSESSMENT; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SWELLING; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TACHYCARDIA; THERMOGRAPHY; TREATMENT RESPONSE; VENOUS PRESSURE; WALKING; WEIGHT REDUCTION;

PULMONARY ARTERIAL HYPERTENSION; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS;

EID: 85027921123     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2013.07.011     Document Type: Review

References (56)

1. N. Galiè, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension European Heart Journal 30 2009 2493 2537
2. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, and J.R. Lindner ACCF/AHA 2009 expert consensus document on pulmonary hypertension Circulation 119 2009 2250 2294
3. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension Journal of the American College of Cardiology 54 2009 S43 S54
4. F.P. Quismorio Jr., O. Sharma, M. Koss, T. Boylen, A.W. Edmiston, and P.J. Thornton Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus Seminars in Arthritis and Rheumatism 13 1984 349 359
5. A. Fluture, S. Chaudhari, and W.H. Frishman Valvular heart disease and systemic lupus erythematosus: therapeutic implications Heart Disease 5 2003 349 353
6. G. Stojan, and M. Petri Atherosclerosis in systemic lupus erythematosus Journal of Cardiovascular Pharmacology 2013 Jun 20 [Epub ahead of print]
7. A. Tincani, C.B. Rebaioli, M. Taglietti, and Y. Shoenfeld Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus Rheumatology 45 2006 iv8 iv13
8. S. Jacobsen, J. Petersen, S. Ullman, P. Junker, A. Voss, and J.M. Rasmussen A multicenter study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analysis of clinical subsets Clinical Rheumatology 17 1998 468 477
9. 2+ release Journal of Physiology 2013 Aug 5 [Epub ahead of print]
10. J.H. Ryu, M.J. Krowka, P.A. Pellikka, K.L. Swanson, and M.D. McGoon Pulmonary hypertension in patients with interstitial lung diseases Mayo Clinic Proceedings 82 2007 342 350
11. M. Petri Update on anti-phospholipid antibodies in SLE: the Hopkins' lupus cohort Lupus 19 2010 419 423
12. J.A. Aviña-Zubieta, D. Lacaille, E.C. Sayre, J. Kopec, H.K. Choi, and J.M. Esdaile Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study Arthritis Research & Therapy 14 2012 A53
13. D. Bonderman, H. Wilkens, S. Wakounig, H.J. Schäfers, P. Jansa, and J. Lindner Risk factors for chronic thromboembolic pulmonary hypertension European Respiratory Journal 33 2009 325 331
14. S.A. Quadrelli, C. Alvarez, S.C. Arce, L. Paz, J. Sarano, and E.M. Sobrino Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies Lupus 18 2009 1053 1060
15. R.A. Asherson, and C.M. Oakley Pulmonary hypertension and systemic lupus erythematosus Journal of Rheumatology 13 1986 1 5
16. A.J. Roncoroni, C. Alvarez, and F. Molinas Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus Respiration 59 1992 52 56
17. G. Ruiz-Irastorza, M. Garmendia, I. Villar, M.V. Egurbide, and C. Aguirre Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy Autoimmunity Reviews 12 2013 410 415
18. A. Prabu, K. Patel, C.S. Yee, P. Nightingale, R.D. Situnayake, and D.R. Thickett Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus Rheumatology 48 2009 1506 1511
19. N. Danchenko, J.A. Satia, and M.S. Anthony Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden Lupus 15 2006 308 318
20. R. Condliffe, D.G. Kiely, A.J. Peacock, P.A. Corris, J.S. Gibbs, and F. Vrapi Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era American Journal of Respiratory and Critical Care Medicine 179 2009 151 157
21. P.M. Hassoun, L. Mouthon, J.A. Barberà, S. Eddahibi, S.C. Flores, and F. Grimminger Inflammation, growth factors, and pulmonary vascular remodeling Journal of the American College of Cardiology 54 2009 S10 S19
22. A. Giaid, M. Yanagisawa, D. Langleben, R.P. Michel, R. Levy, and H. Shennib Expression of endothelin-1 in the lungs of patients with pulmonary hypertension New England Journal of Medicine 328 1993 1732 1739
23. V.V. McLaughlin, and M.D. McGoon Pulmonary arterial hypertension Circulation 114 2006 1417 1431
24. M. Rabinovitch Molecular pathogenesis of pulmonary arterial hypertension Journal of Clinical Investigation 122 2012 4306 4313
25. M.J. Connolly, and P.I. Aaronson Key role of the RhoA/Rho kinase system in pulmonary hypertension Pulmonary Pharmacology & Therapeutics 24 2011 1 14
26. J. Isgro, S. Gupta, E. Jacek, T. Pavri, R. Duculan, and M. Kim Enhanced Rho-associated protein kinase activation in patients with systemic lupus erythematosus Arthritis & Rheumatism 65 2013 1592 1602
27. A. Shahane Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis Rheumatology International 33 2013 1655 1667
28. M. Magliano, D.A. Isenberg, and J. Hillson Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis & Rheumatism 46 2002 1997 2009
29. T. Yoshio, J. Masuyama, and M. Sumiya Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus Journal of Rheumatology 21 1994 2058 2063
30. C. Belizna, A. Duijvestijn, M. Hamidou, and J.W. Tervaert Antiendothelial cell antibodies in vasculitis and connective tissue disease Annals of the Rheumatic Diseases 65 2006 1545 1550
31. J.Y. Shen, S.L. Chen, Y.X. Wu, R.Q. Tao, Y.Y. Gu, and C.D. Bao Pulmonary hypertension in systemic lupus erythematosus Rheumatology International 18 1999 147 151
32. A. Dhala Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction Clinical and Developmental Immunology 2012 2012 854941
33. N. Sasaki, A. Kamataki, and T. Sawai A histopathological study of pulmonary hypertension in connective tissue disease Allergology International 60 2011 411 417
34. L. Chung, J. Liu, L. Parsons, P.M. Hassoun, M. McGoon, and D.B. Badesch Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype Chest 138 2010 1383 1394
35. A. Cefle, M. Inanc, M. Sayarlioglu, S. Kamali, A. Gul, and L. Ocal Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome Rheumatology International 31 2011 183 189
36. M.J. Connolly, and G. Kovacs Pulmonary hypertension: a guide for GPs British Journal of General Practice 62 2012 795 797
37. J.S. Fritz, C. Blair, R.J. Oudiz, C. Dufton, H. Olschewski, and D. Despain Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension Chest 143 2013 315 323
38. F. Lian, D. Chen, Y. Wang, Y. Ye, X. Wang, and Z. Zhan Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus Rheumatology International 32 2012 1727 1731
39. B.E. Schreiber, C. Valerio, and C.E. Handler Diagnosis and prognosis of pulmonary arterial hypertension in SLE and SSc Rheumatology 50 2011 40 [Oxford Univ Press]
40. C.H. Jeon, J.Y. Chai, and Y.I. Seo Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry International Journal of Rheumatic Disease 15 2012 e80 e89
41. N. Tunariu, S.J. Gibbs, and Z. Win Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension Journal of Nuclear Medicine 48 2007 680 684
42. D. Montani, L. Savale, and D. Natali Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension European Heart Journal 31 2010 1898 1907
43. R.J. Barst, L.J. Rubin, and W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for PPH New England Journal of Medicine 334 1996 296 301
44. N. Galiè, A. Manes, and L. Negro A meta-analysis of randomized controlled trials in pulmonary arterial hypertension European Heart Journal 30 2009 394 403
45. M.M. Hoeper, R.J. Barst, and R.C. Bourge Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study Circulation 127 2013 1128 1138
46. I.M. Robbins, S.P. Gaine, and R. Schilz Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus Chest 117 2000 14 18
47. G.A. Heresi, and O.A. Minai Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy Respiratory Medicine 101 2007 2099 2107
48. Y. Shirai, H. Yasuoka, and T. Takeuchi Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center Modern Rheumatology 2013 Jan 29 [Epub ahead of print]
49. S. Mavrogeni, K. Bratis, and V. Markussis The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis Lupus 22 2013 34 43
50. G.M. Zawadowski, K.W. Klarich, and K.G. Moder A contemporary case series of lupus myocarditis Lupus 13 2012 1378 1384
51. S. Hennigan, R.N. Channick, and G.J. Silverman Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report Lupus 17 2008 754 756
52. X. Jais, D. Launay, A. Yaici, J. Le Pavec, C. Tchérakian, and O. Sitbon Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases Arthritis & Rheumatism 58 2008 521 531
53. S.M. Chung, C.K. Lee, E.Y. Lee, B. Yoo, S.D. Lee, and H.B. Moon Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension Clinical Rheumatology 25 2006 866 872
54. G.E. D'Alonzo, R.J. Barst, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, and K.M. Detre Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Annals of Internal Medicine 115 1991 343 349
55. R.L. Benza, D.P. Miller, R.J. Barst, D.B. Badesch, A.E. Frost, and M.D. McGoon An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry Chest 142 2012 448 456
56. M. Humbert, O. Sitbon, A. Yaïci, D. Montani, D.S. O'Callaghan, and X. Jaïs Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension European Respiratory Journal 36 2010 549 555